Drug tested to tame unbearable itch of severe skin condition
NCT ID NCT05451316
Summary
This study observed how well an approved drug, upadacitinib, works for people in Japan with a severe form of atopic dermatitis that causes intensely itchy, painful skin bumps called prurigo nodularis. About 200 participants took the oral medication daily for 48 weeks as part of their normal care. The main goal was to see how many people experienced a meaningful reduction in their worst itching.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tohoku Medical and Pharmaceuti /ID# 252486
Sendai, Miyagi, 983-0005, Japan
Conditions
Explore the condition pages connected to this study.